Weiguo Dong

Weiguo Dong

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
JZJixiang Zhang
Jixiang Zhang
XWXiaoli Wang
Xiaoli Wang
VVVikash Vikash
Vikash Vikash
QYQing Ye
Qing Ye
DWDandan Wu
Dandan Wu
WDWeiguo Dong
Weiguo Dong
It has long been recognized that an increase of reactive oxygen species (ROS) can modify the cell‐signaling proteins and have functional consequences, which successively mediate pathological processes such as atherosclerosis, diabetes, unchecked growth, neurodegeneration, inflammation, and aging. While numerous articles have demonstrated the impacts of ROS on various signaling pathways and clarify the mechanism of action of cell‐signaling proteins, their influence on the level of intracellular ROS, and their complex interactions among multiple ROS associated signaling pathways, the systemic summary is necessary. In this review paper, we particularly focus on the pattern of the generation and homeostasis of intracellular ROS, the mechanisms and targets of ROS impacting on cell‐signaling proteins (NF‐κB, MAPKs, Keap1‐Nrf2‐ARE, and PI3K‐Akt), ion channels and transporters (Ca2+ and mPTP), and modifying protein kinase and Ubiquitination/Proteasome System.

1 January 2021 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
QXQiutang Xiong
Qiutang Xiong
MXMing Xu
Ming Xu
JLJiao Li
Jiao Li
YLYinghui Liu
Yinghui Liu
JZJixiang Zhang
Jixiang Zhang
WDWeiguo Dong
Weiguo Dong

1 June 2020 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
JZJ. Zhang
J. Zhang
XWX. Wang
X. Wang
XJX. Jia
X. Jia
JLJ. Li
J. Li
KHK. Hu
K. Hu
WDWeiguo Dong
Weiguo Dong

24 February 2020 in Aging
Verified
Journal Article
Open access
STShan Tian
Shan Tian
PPPailan Peng
Pailan Peng
JLJiao Li
Jiao Li
HDHuan Deng
Huan Deng
NZNa Zhan
Na Zhan
WDWeiguo Dong
Weiguo Dong
In this study, we investigated the role of SERPINH1 in gastric cancer (GC) progression. GC patient tissues show significantly higher SERPINH1 mRNA and protein levels than normal gastric mucosal tissues. GC patients with high SERPINH1 expression are associated with lymph node metastasis and poor prognosis. SERPINH1 mRNA levels negatively correlate with E-cadherin mRNA levels and positively correlate with levels of N-cadherin, MMP2, and MMP9 mRNA levels. This suggests SERPINH1 regulates epithelial to mesenchymal transition (EMT). SERPINH1 expression was significantly higher in the HGC-27, AGS, MGC-803, and SGC-7901 GC cell lines than in the GES-1 normal gastric mucosal cell line. In SERPINH1-silenced SGC-7901 cells, survival, colony formation, migration and invasion were all reduced, whereas they were all enhanced in SERPINH1-overexpressing MGC-803 cells. Levels of WNT/β-catenin signaling pathway proteins, including β-catenin, Wnt2, GSK-3β, p-GSK-3β, NF-κB P65, Snail1, Slug and TWIST, were all reduced in SERPINH1-silenced SGC-7901 cells, and increased in the SERPINH1-overexpressing MGC-803 cells. Inhibition of SERPINH1 protein using Co1003 significantly decreased survival, invasion, and migration of GC cells. SERPINH1 thus appears to regulate EMT and GC progression via the Wnt/β-catenin pathway, making SERPINH1 a potential prognostic biomarker and therapeutic target in GC patients.

1 January 2020 in Theranostics
Verified
Journal Article
Open access
YCYongyu Chen
Yongyu Chen
YCYan Chen
Yan Chen
JZJixiang Zhang
Jixiang Zhang
PCPan Cao
Pan Cao
WSWenhao Su
Wenhao Su
WDWeiguo Dong
Weiguo Dong
Aims: We aimed to measure the abundance of Fusobacterium nucleatum (F. nucleatum) in colorectal cancer (CRC) tissues from patients and to uncover the function of this bacterium in colorectal tumor metastasis.

17 June 2016 in ACS Nano
Verified
Journal Article
Closed access
SLSong-Wei Lv
Song-Wei Lv
YLYa Liu
Ya Liu
MXMin Xie
Min Xie
JWJing Wang
Jing Wang
XYXue-Wei Yan
Xue-Wei Yan
WHWeihua Huang
Weihua Huang